Effects of gonadal steroids and their antagonists on dna synthesis in human vascular cells

Hypertension

Volumn 32, Issue 1, 1998, Pages 39-45

  Somjen, Dalia ^a   Kohen, Fortune ^b   Jaffe, Anat ^a   Amir Zaltsman, Yehudit ^b   Knoll, Esther ^a   Stern, Naftali ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Dihydrotesterone; Estradiol; Flutamide; Muscle, smooth, vascular; Raloxifene; Tamoxifen

Indexed keywords

ANDROSTANOLONE; DNA; ESTRADIOL; FLUTAMIDE; RALOXIFENE; SEX HORMONE; SEX HORMONE ANTAGONIST; TAMOXIFEN;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0031903106     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.1.39     Document Type: Article

References (21)

1. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women: the Atherosclerosis Risk in Communities Study investigations. N Engl J Med. 1993;28:1069-1075.
2. Koh KK, Mincemoyer R, Bui MN, Csako G, Pucino F, Guetta V, Waclawiw M, Cannon RO. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med. 1997;336: 683-690.
3. Node K, Kitakaze M, Kosaka H, Minamino T, Funaya H, Hori M. Amelioration of ischemia and reperfusion-induced myocardial injury by 17β-estradiol: role of nitric oxide and calcium-activated potassium channels. Circulation. 1997;96:1953-1963.
4. Williams JK, Honoré EK, Adams DUM. Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates. Circulation. 1997;96:1970-1975.
5. Pines A, Fisman EZ, Levo Y, Auerbuch M, Lidor A, Drory Y, Finkelstein A, Hetman-Peri M, Moshkovitz M, Ben-Ari E, Ayalon D. The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol. 1991;164:806-812.
6. Oparil S, Levine RL, Chen YF. Sex hormones and the vasculature. In: Sowers JR, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:225-227.
7. Kaye AM, Reiss N, Weisman Y, Binderman I, Somjen D, Hormonal regulation of creatine kinase BB. In: Brautbaur N, ed. Myocardial and Skeletal Muscle Bioenergetics. New York, NY: Plenum Press; 1986:83-101.
8. Malnick SDH, Shaer A, Soreq H, Kaye AM. Estrogen-induced creatine kinase in the reproductive system of the immature female rat. Endocrinology. 1983;113:1907-1909.
9. Somjen D, Weisman Y, Harell A, Berger E, Kaye AM. Direct and sex-specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone. Proc Natl Acad Sci USA. 1989;86: 3361-3365.
10. Mor G, Amir-Zaltsman Y, Barnard G, Kohen F. Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors. Endocrinology. 1992;130:3633-3640.
11. Somjen D, Amir-Zaltsman Y, Mor G, Gayer B, Lichter S, Nevo N, Kohen F. A monoclonal antibody to oestradiol attenuates the stimulation of the specific activity of the brain type creatine kinase by estrogen in vivo and in vitro. J Endocrinol. 1997. In press.
12. Kisch E, Jaffe A, Knoll E, Stern N. Role of the lipoxygenase pathway in angiotensin II-induced vasoconstriction in the human placenta. Hypertension. 1997;29:796-801.
13. Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
14. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577-584.
15. Sullivan TR, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith O'Dunnel TF, Mendelson ME. Estrogen inhibits the response to injury in a mouse carotid artery model. J Clin Invest. 1995;96:2482-2488.
16. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
17. Morey AK, Pedram A, Prins BA, Hu RM, Beisiada E, Stanley ER. Estrogen and progesterone inhibit human vascular smooth muscle proliferation. In: Program and abstracts of the 10th International Congress of Endocrinology; June 11-15, 1996: San Francisco, Calif. Abstract.
18. Somjen D, Waisman A, Kaye AM. Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo. J Steroid Biochem Mol Biol. 1996;59: 389-396.
19. Somjen E, Amir-Zaltsman Y, Gayer B, Mor G, Jaccord N, Weisman Y, Barnard G, Kohen F. Anti-idiotypic antibody as an estrogen mimetic: removal of Fc fragment converts agonist to antagonist. J Endocrinol. 1995;145:409-416.
20. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med. 1997;3:545-548.
21. McDonald CC, Stewart HJ. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial: the Scottish Breast Cancer Committee. Br Med J. 1993;303:435-437.